What Is the Order?
Premia Solutionz Private Limited has awarded Highness Microelectronics a purchase order worth ₹6 Crore. This contract covers the production and supply of specialized medical displays, equipment accessories, and backlight units. The transaction is categorized as a domestic order, with the company expected to complete the delivery within a timeline of 16 to 20 weeks.
The consideration includes all applicable taxes and freight costs, marking a notable milestone in the company’s current order book for the specialized medical electronics vertical. This order strengthens the company's positioning as a reliable supplier in the healthcare technology supply chain.
Business Impact
The contract provides substantial revenue visibility for the upcoming two quarters, given the 16-to-20-week execution window. For a company with an annual operating revenue of ₹16.12 Crore, a single order of ₹6 Crore represents nearly 37% of its total yearly turnover. This influx of work reinforces Highness Microelectronics' operational scale and strengthens its relationship with Premia Solutionz.
The deal aligns with the company's growth trajectory, having recently recorded a net profit growth of 62.69% on an annual basis, signaling continued momentum in its niche manufacturing operations and improving cash flow potential from operating activities.
Business Overview
- Highness Microelectronics specializes in the manufacturing and distribution of specialized electronic components.
- Core product segments include high-performance displays, backlight units, and customized electronic accessories.
- The company serves diverse sectors, with a particular focus on medical imaging and industrial electronics.
- Operational facilities include a registered office in Sakinaka and a manufacturing unit in the TTC Industrial Area, Rabale.
- The company maintains a strong promoter backing with a 64.96% stake and zero pledged shares reported.
Financial Context
Highness Microelectronics currently trades at a P/E TTM of 29.88x, which is lower than the broader industry P/E of 93.04x and the sector average of 41.39x. The company has shown robust financial health with a Piotroski Score of 5 and an annual Return on Equity of 15.1%. Market momentum is evident, with the stock price rising 27.07% over the past month to reach a 3-year high of 237.5.
Technical indicators show the stock is currently trading above its 30-day, 50-day, and 100-day Simple Moving Averages, though the Relative Strength Index of 73.06 indicates the stock has entered overbought territory.
